Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

a study on Meningioma Brain Tumor Brain Cancer

Summary

Eligibility
for people ages 18 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at San Francisco, California
Dates
study started
study ends around
Principal Investigator
by David Raleigh, MD, PhD
Headshot of David Raleigh
David Raleigh

Description

Summary

Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.

Official Title

An Investigation of Tumor Genomics, Individual Risk Factors, and External Drivers of Health to Improve Health Outcomes for Patients With Meningioma

Details

PRIMARY OBJECTIVES:

  1. To assess prevalence and distribution of social and structural determinants of health (SSDH) among meningioma patients.

II. To assess disparities in SSDH among meningioma patients of different races.

OUTLINE: This is an observational study.

Participants will complete a survey and have their medical records reviewed.

Keywords

Meningioma of Brain, Meningioma, Brain Tumor, Brain Neoplasms, Surveys and Questionnaires, Medical Record Review

Eligibility

You can join if…

Open to people ages 18 years and up

  • Adults ≥18 years of age
  • Able to speak and read English
  • Diagnosed with a meningioma

You CAN'T join if...

  • Active psychiatric issues (suicidality, active psychosis, grave disability, etc.)
  • Inability to consent secondary to severe neurologic deficit or psychiatric distress
  • Inability to complete survey secondary to severe neurologic deficit or psychiatric distress

Location

  • UCSF accepting new patients
    San Francisco California 94143 United States

Lead Scientist at UCSF

  • David Raleigh, MD, PhD
    Dr. David Raleigh is a radiation oncologist who specializes in brain tumors. He cares for both adult and pediatric patients. Raleigh's research focuses on understanding the biological processes that cause brain tumors to grow. His goals are to uncover new measures of brain cancer and to identify cells for drugs to target.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT07418775
Study Type
Observational
Participants
Expecting 3000 study participants
Last Updated
Contact us about this trial